Consult the medical resource doctors trust

UpToDate is one of the most respected evidence-based medical information resources in the world, used by over 400,000 doctors and thousands of patients to find answers to medical questions.

  • Content written by a faculty of over 4,000 physicians from leading medical institutions
  • Unbiased: free of advertising or pharmaceutical funding
  • Evidence-based treatment recommendations
  • Continuously updated to incorporate new medical findings

NSAIDs (including aspirin): Allergic and pseudoallergic reactions

INTRODUCTION

Nonsteroidal antiinflammatory drugs (NSAIDs), including aspirin (ASA), are associated with an array of adverse effects, ranging from mild gastritis to life-threatening allergic reactions. (See "Nonselective NSAIDs: Overview of adverse effects".)

The ingestion of NSAIDs can give rise to several allergic and "pseudoallergic" reactions. Allergic reactions are abnormal immunologic reactions to NSAIDs, while pseudoallergic reactions are non-immunologic reactions that are believed to result from acquired alterations in the biochemical pathways upon which NSAIDs act.

The prevalence of allergic and pseudoallergic reactions to NSAIDs in the general population is not known. These reactions occur in both children and adults, and they are almost always acquired (rather than present from birth). Symptoms include rhino-conjunctivitis, bronchospasm, urticaria/angioedema, and anaphylaxis.

In addition to allergic reactions, there are various types of idiosyncratic adverse reactions to NSAIDs/ASA that are presumed or known to involve other types of immune mechanisms. These include, but are not limited to, aseptic meningitis, hypersensitivity pneumonitis, thrombocytopenia, interstitial nephritis, erythema multiforme, fixed drug eruptions, toxic epidermal necrolysis, Stevens Johnson syndrome, erythema nodosum, maculopapular eruptions, and bullous leukocytoclastic vasculitis [1]. These types of reactions are discussed in various topic reviews. (See "Nonselective NSAIDs: Overview of adverse effects" and "Drug eruptions" and "Stevens-Johnson syndrome and toxic epidermal necrolysis: Clinical manifestations; pathogenesis; and diagnosis", and see other specific topic reviews).

The clinical manifestations of allergic and pseudoallergic reactions caused by NSAIDS/ASA will be reviewed here. The challenge protocols used by allergy specialists to evaluate and manage affected patients are presented separately. (See "Diagnostic challenge and desensitization protocols for NSAID reactions".)

» To continue reading this article you need to login or subscribe.

Ready to join over 400,000 satisfied users? Subscribe to read this article and others like it.
Last literature review version 18.2: May 2010
This topic last updated: May 11, 2010
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use (click here) ©2010 UpToDate, Inc.
References
Top
  1. Stevenson, D, Sanchez-Borges, M, Szczeklik, A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 2001; 87:177.
  2. Warin, RP. The effect of aspirin in chronic urticaria. Br J Dermatol 1960; 72:350.
  3. Moore-Robinson, M, Warin, RP. Effect of salicylates in urticaria. Br Med J 1967; 4:262.
  4. Champion, RH, Roberts, SO, Carpenter, RG, Roger, JH. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 1969; 81:588.
  5. Mathison, DA, Lumry, WR, Stevenson, DD, et al. Aspirin in chronic urticaria and/or angioedema: Studies of sensitivity and desensitization. J Allergy Clin Immunol 1982; 69:135.
  6. Stevenson, DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984; 74:617.
  7. Setkowicz, M, Mastalerz, L, Podolec-Rubis, M, et al. Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years. J Allergy Clin Immunol 2009; 123:174.
  8. Asero, R. Multiple sensitivity to NSAID. Allergy 2000; 55:893.
  9. Sanchez-Borges, M, Capriles-Hulett, A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 2000; 84:101.
  10. Quiralte, J, Blanco, C, Castillo R, et al: Anaphylactoid reactions due to nonsteroidal antiinflammatory drugs: clinical and cross-reactivity studies. Ann Allergy Asthma Immunol 1997; 78:293.
  11. Berkes, EA. Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol 2003; 24:137.
  12. Blanca, M, Perez, E, Garcia, JJ, et al. Angioedema and IgE antibodies to aspirin: a case report. Ann Allergy 1989; 62:295.
  13. Szczeklik, A. Adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. Ann Allergy 1987; 59:113.
  14. Strom, BL, Carson, JL, Schinnar, R, et al. The effect of indication on the risk of hypersensitivity reactions associated with tolmetin sodium vs other nonsteroidal antiinflammatory drugs. J Rheumatol 1988; 15:695.
  15. van der, Klauw MM, Stricker, BH, Herings, RM, et al. A population based case-cohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993; 35:400.
  16. Ross, JE. Naproxen-induced anaphylaxis. A case report. Am J Forensic Med Pathol 1994; 15:180.
  17. Alkhawajah, AM, Eifawal, M, Mahmoud, SF. Fatal anaphylactic reaction to diclofenac. Forensic Sci Int 1993; 60:107.
  18. Levy, MB, Fink, JN. Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 2001; 87:72.
  19. Fontaine, C, Bousquet, PJ, Demoly, P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J Allergy Clin Immunol 2005; 115:633.
  20. Van Diem, L, Grilliat, JP. Anaphylactic shock induced by paracetamol. Eur J Clin Pharmacol 1990; 38:389.
  21. Leung, R, Plomley, R, Czarny, D. Paracetamol anaphylaxis. Clin Exp Allergy 1992; 22:831.
  22. Gyllfors, P, Bochenek, G, Overholt, J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003; 111:1116.
  23. Woessner, KM, Simon, RA, Stevenson, DD. The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum 2002; 46:2201.
  24. Stevenson, DD, Simon, RA, Zuraw, BL. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs. In: Middleton's Allergy: Principles and Practice, 6th Ed, Adkinson, NF, Yunginger, JW, Busse, WW, et al (Eds), Mosby, St Louis, MO 2003. p.1695.
  25. Wong, JT, Nagy, CS, Krinzman, SJ, et al. Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema. J Allergy Clin Immunol 2000; 105:997.
  26. Simon, RA. Prevention and Treatment of Reactions to NSAIDs. Clin Rev Allergy Immunol 2003; 24:189.
NSAIDs (including aspirin): Allergic and pseudoallergic reactions Mechanism and treatment of edema in nephrotic syndrome Patient information: Hip pain Postnatal care of hydrops fetalis Overview of the treatment and prognosis of attention deficit hyperactivity disorder in children and adolescents Saline infusion sonohysterography Emergency care of moderate and severe thermal burns in children Infant benefits of breastfeeding Patient information: Seborrheic dermatitis (including dandruff and cradle cap) Bronchioloalveolar carcinoma